Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Depreotide

Known as: Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl), (1-1')-sulfide with 3-(2-mercaptoacetamido)-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Radiolabeled peptides targeted against receptors on the cell surface have been shown to be remarkably specific and effective in… 
  • table 1
  • figure 1
Highly Cited
2008
Highly Cited
2008
PURPOSE To perform a meta-analysis to estimate the diagnostic accuracy of dynamic contrast material-enhanced computed tomography… 
2006
2006
UNLABELLED In vitro assessment of hormone receptor status using a ligand-binding assay or immunohistochemistry in breast cancer… 
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2005
2005
PurposeThe purpose of the study was to compare 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and 99mTc… 
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
2005
2005
AIM (177)Lu-DOTA-Tyr(3)-octreotate is a candidate radiopharmaceutical for the therapy of somatostatin receptor (sstr)-positive… 
2004
2004
STUDY OBJECTIVES The findings from conventional imaging modalities, such as chest CT, are frequently unreliable in patients with… 
2004
2004
Purpose: To evaluate the diagnostic value of a new somatostatin analog, 99mTc-Depreotide, in differentiating benign from… 
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
2002
Review
2002
Several tumors overexpress somatostatin receptors (SSTR) and can thus be imaged with radiolabeled analogues of somatostatin. Tc… 
2002
2002
PURPOSETc-99m depreotide is a peptide analogue of a somatostatin receptor that preferentially binds to somatostatin receptors 2… 
Highly Cited
2000
Highly Cited
2000
OBJECTIVE The affinity of various malignant neoplasms including small cell and non-small cell lung cancer for peptide analogs of…